News

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that based on submitted stability data, the U.S. FDA has authorized the Moderna COVID-19 Vaccine to be kept at room temperature conditions once removed from the...

Healthcare providers across Canada will soon be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum®. Auxita solves the administrative burden for providers by digitizing workflows and providing interoperability with patient support...

OSE Immunotherapeutics announced that the Belgian Federal Agency for Medicines and Health Products (Agence Fédérale des Médicaments et des Produits de Santé - AFMPS) and the Belgian Ethics Committee approved the Phase 1 trial evaluating its COVID-19 vaccine, named...

Pfizer Inc. and BioNTech SE announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody...

Roche announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark. Roche will file for approval with the FDA in the future. The Elecsys® EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV...

CoolMed, specialists in medical refrigeration, have strengthened their product offering with the launch of theCoolMed Portable Vaccine Carrier. The carrier is designed to enable healthcare professionals to easily transport vaccines, solving the problem of cold chain compliance on the move...

Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1 trial for nafamostat inhalation formulation (DS-2319), which is being developed as a potential medicine for the treatment of the novel coronavirus infectious disease (hereinafter,...